Literature DB >> 1546863

Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging.

B Cryer1, E Lee, M Feldman.   

Abstract

OBJECTIVE: To evaluate behavioral, demographic, clinical, and histologic variables that independently influence gastroduodenal mucosal prostaglandin concentrations.
DESIGN: Prospective study.
SETTING: A clinical research laboratory located in a Department of Veterans Affairs hospital. PATIENTS: Fifty-two healthy adults who had no history of peptic ulcer disease and who were not receiving nonsteroidal anti-inflammatory drugs. MEASUREMENTS: Mucosal biopsy specimens were obtained endoscopically from the stomach (body and antrum) and the duodenum (bulb and postbulbar area). Mucosal extracts from each of these four regions were assessed by radioimmunoassay to determine prostaglandin E2 and prostaglandin F2 alpha concentrations. Specimens were also examined histologically for inflammation and the presence of Helicobacter pylori. A multivariate linear regression model was used to determine which behavioral, demographic, and histologic variables significantly and independently influenced gastroduodenal mucosal prostaglandin concentrations.
RESULTS: Smoking and older age were independently associated with lower prostaglandin concentrations in all four mucosal regions (P = 0.0001 to P = 0.05). Compared with results in young nonsmokers, mucosal prostaglandin concentrations were reduced by 70% to 80% in older smokers. Gender, alcohol use, endoscopic appearance, dyspeptic symptoms, mucosal inflammation, and the presence of H. pylori had no consistent effect on prostaglandin content.
CONCLUSION: Smoking and older age are associated with significantly reduced gastric and duodenal prostaglandin concentrations. These observations may help explain the predisposition to ulcer disease in smokers and older persons.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546863     DOI: 10.7326/0003-4819-116-8-636

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

1.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

Review 2.  Effect of age-related changes in gastric physiology on tolerability of medications for older people.

Authors:  Julia L Newton
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Pharmacologic options in the management of upper gastrointestinal bleeding: focus on the elderly.

Authors:  Moe Htet Kyaw; Francis Ka Leung Chan
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

Review 4.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

5.  Aging enhances susceptibility of diclofenac-treated rats to gastric ulceration, while attenuating enteropathy.

Authors:  C R Atchison; A Balakumaran; A B West; W E Hoffmann; M Treinen-Moslen
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

6.  Cigarette smoke increases gastric ulcer size in part by an angiotensin II-mediated mechanism in rats.

Authors:  K Seno; J H Zhu; J D Barrett; P Eggena; O U Scremin; K Lam; J W Leung; F W Leung
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

7.  Prostaglandin E2 and prostaglandin F2 alpha biosynthesis in human gastric mucosa: effect of chronic alcohol misuse.

Authors:  C Bode; G Maute; J C Bode
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

8.  Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; M Balsitis; S Everitt; C J Hawkey
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

9.  Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; M Balsitis; F Filipowicz; C J Hawkey
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

Review 10.  Improving the gastrointestinal tolerability of aspirin in older people.

Authors:  Julia L Newton
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.